Compound Detail
CHEMBL4460529
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4460529 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZABJXVCFZXHWQG-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
477.2
MW (Da)
3.17
ALogP
8
HBA
3
HBD
125.1
PSA (Ų)
0.19
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.98
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 CHEMBL4685 | IC50 | 6.98 | 6.935 | 104.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 104.0 | nM | 6.98 | Inhibition of IDO1 in human HeLa cells using L-tryptophan as substrate incubated... | 31445231 |
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 130.0 | nM | 6.89 | Inhibition of recombinant N-terminal His-tagged human IDO1 expressed in Escheric... | 31445231 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31445231 | 10.1016/j.ejmech.2019.111629 | Indoleamine 2,3-dioxygenase 1 | 2 |
Data from ChEMBL 36 via Core Engine